CLOUGH CAPITAL PARTNERS L P - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.

Quarter-by-quarter ownership
CLOUGH CAPITAL PARTNERS L P ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$7,623,157
+314.6%
83,679
+200.2%
0.77%
+287.4%
Q1 2023$1,838,899
+24.3%
27,879
-2.6%
0.20%
+32.0%
Q4 2022$1,479,371
-49.2%
28,609
-32.9%
0.15%
-51.6%
Q3 2022$2,910,000
-54.8%
42,609
-70.1%
0.31%
-61.2%
Q2 2022$6,440,000
-11.0%
142,4090.0%0.80%
+45.5%
Q1 2022$7,236,000
+16.2%
142,409
+8.1%
0.55%
+32.0%
Q4 2021$6,229,000
+37.2%
131,749
-4.4%
0.42%
+51.3%
Q3 2021$4,540,000
-47.9%
137,7490.0%0.28%
-41.9%
Q2 2021$8,706,000
-58.5%
137,749
-71.8%
0.47%
-49.5%
Q1 2021$20,989,000
+57.9%
489,149
+110.4%
0.94%
-0.8%
Q4 2020$13,296,000
+8.6%
232,449
-42.7%
0.94%
+7.3%
Q3 2020$12,244,000
-7.6%
405,8340.0%0.88%
-32.1%
Q2 2020$13,255,000
+21.9%
405,8340.0%1.30%
+20.0%
Q1 2020$10,872,000
-31.6%
405,834
-21.8%
1.08%
-20.3%
Q4 2019$15,887,000
+27.1%
518,8340.0%1.36%
+31.1%
Q3 2019$12,499,000
-16.7%
518,834
-12.4%
1.03%
-29.8%
Q2 2019$15,005,000
+30.5%
592,134
+0.4%
1.47%
+46.3%
Q1 2019$11,500,000
+54.9%
589,734
+4.8%
1.01%
+15.4%
Q4 2018$7,422,000
-29.1%
562,734
-4.5%
0.87%
-11.7%
Q3 2018$10,474,000
-17.6%
589,116
+2.0%
0.99%
-13.0%
Q2 2018$12,708,000
-7.1%
577,616
-7.1%
1.14%
-13.2%
Q1 2018$13,673,000
-30.5%
621,616
-32.2%
1.31%
-20.2%
Q4 2017$19,667,000917,1161.64%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders